Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1875 of 2026 entries
View as:

A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site

Phase: N/A Priority: Normal
NCT ID: NCT03498521 Org: User:
Start: 07/10/18 End: 11/07/24 Due: 11/07/25

A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01045083 Org: User:
Start: 01/31/10 End: 06/30/11 Due: 06/30/12

A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ)

Phase: N/A Priority: Normal
NCT ID: NCT04933227 Org: User:
Start: 08/06/21 End: 11/17/23 Due: 11/17/24

A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT04158648 Org: User:
Start: 02/10/20 End: 12/31/25 Due: 12/31/26

A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)

Phase: N/A Priority: Normal
NCT ID: NCT04299464 Org: User:
Start: 03/31/21 End: 05/15/24 Due: 05/15/25

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)

Phase: N/A Priority: Normal
NCT ID: NCT04586010 Org: User:
Start: 03/17/21 End: 11/30/27 Due: 11/30/28

A Study of RO4917523 in Patients With Treatment Resistant Depression

Phase: N/A Priority: Normal
NCT ID: NCT00809562 Org: User:
Start: 03/31/09 End: 02/28/11 Due: 02/28/12

A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03478956 Org: User:
Start: 03/27/18 End: 09/27/23 Due: 09/27/24

A Study of Xenical (Orlistat) in Overweight and Obese Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00940628 Org: User:
Start: 04/30/08 End: 09/30/10 Due: 09/30/11

A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT00327535 Org: User:
Start: 05/31/06 End: 05/31/07 Due: 05/31/08

A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT04790903 Org: User:
Start: 07/02/21 End: 05/21/24 Due: 05/21/25

A Study to Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib for the Treatment of Intermediate- or High-Risk Myelofibrosis (MF)

Phase: N/A Priority: Normal
NCT ID: NCT02593760 Org: User:
Start: 01/25/16 End: 07/12/17 Due: 07/12/18

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02132949 Org: User:
Start: 07/14/14 End: 08/25/20 Due: 08/25/21

An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1

Phase: N/A Priority: Normal
NCT ID: NCT01750216 Org: User:
Start: 07/31/12 End: 01/31/15 Due: 01/31/16

A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT05548556 Org: User:
Start: 02/07/23 End: 11/02/26 Due: 11/02/27

Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A

Phase: N/A Priority: Normal
NCT ID: NCT02406092 Org: User:
Start: 10/13/15 End: 06/30/21 Due: 06/30/22

Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04665856 Org: User:
Start: 12/21/20 End: 06/30/26 Due: 06/30/27

Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253

Phase: N/A Priority: Normal
NCT ID: NCT01237496 Org: User:
Start: 07/31/05 End: 09/30/09 Due: 09/30/10

A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01183598 Org: User:
Start: 08/31/06 End: 11/30/11 Due: 11/30/12

ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

Phase: N/A Priority: Normal
NCT ID: NCT00545090 Org: User:
Start: 08/31/06 End: 06/30/08 Due: 06/30/09

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

Phase: N/A Priority: Normal
NCT ID: NCT01033734 Org: User:
Start: 12/31/10 End: 12/31/12 Due: 12/31/13

A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab

Phase: N/A Priority: Normal
NCT ID: NCT01461928 Org: User:
Start: 12/20/11 End: 06/02/18 Due: 06/02/19

Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants

Phase: N/A Priority: Normal
NCT ID: NCT02596958 Org: User:
Start: 09/30/07 End: 10/31/13 Due: 10/31/14

A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00559845 Org: User:
Start: 02/29/08 End: 07/31/15 Due: 07/31/16

Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART)

Phase: N/A Priority: Normal
NCT ID: NCT01089413 Org: User:
Start: 01/31/10 End: 06/30/13 Due: 06/30/14